CJC-1295 + Ipamorelin 10mg

CJC-1295 (No DAC) + Ipamorelin at a glance

Two peptides are co-lyophilized here. CJC-1295 without DAC, more precisely called Modified GRF 1-29, is a version of the active 1-29 portion of GHRH with substitutions at several positions that make it harder for enzymes to break down. Ipamorelin is a synthetic pentapeptide that acts on the ghrelin receptor. Neither molecule carries the Drug Affinity Complex, the albumin-binding group found in CJC-1295 with DAC, so both remain short-acting in pharmacology studies.

Price and availability

This is Core Peptides‘s single 10mg vial, dispatched from the United States. $85.00 buys the whole kit, which is $8.50/mg. 5 brands sell CJC-1295 (No DAC) + Ipamorelin on GLP1 Forum Escrow, with a typical price of $0.891–$0.891 per mg (median $0.891); this listing is above the typical range. Checkout goes into escrow first; the funds move to Core Peptides once delivery is confirmed.

What it is studied for

The two components act through different receptors on the same pituitary cells. Modified GRF 1-29 binds the GHRH receptor, while Ipamorelin binds GHS-R1a, the receptor for the stomach hormone ghrelin. GHRH signaling raises cyclic AMP, whereas ghrelin-receptor signaling works mainly through calcium and also opposes the inhibitory effect of somatostatin. Researchers pair them to see how two distinct inputs shape a growth hormone pulse. Ipamorelin is noted in the literature for releasing growth hormone with little measured effect on cortisol or prolactin in animal studies.

Research and regulatory status

Each peptide has a preclinical record, and Ipamorelin was also tested in early human trials for postoperative ileus without reaching approval. The pairing is common in research on GH secretion patterns, body composition and recovery, typically using pituitary cell assays or animal models. Neither component, nor the blend, is an approved medicine, and both fall within the World Anti-Doping Agency prohibited list.

Checking the lab data

A blend report should identify both peptides individually. Mass spectrometry should confirm Modified GRF 1-29 and Ipamorelin at their expected masses, and an HPLC trace should separate the two peaks and quantify each against the labeled amounts. A version containing DAC would show a much heavier mass, so the result also confirms the No DAC form. Expect a white, uniform freeze-dried cake and a batch number matching the vial.

No independent report is attached to this listing yet. You can compare brands that publish one on the CJC-1295 (No DAC) + Ipamorelin page or browse the lab reports directory.

Listing details

Compound

CJC-1295 (No DAC) + Ipamorelin

Synonyms

Mod GRF 1-29 + Ipamorelin blend

Class

GHRH analogue / ghrelin-receptor agonist combination

Format

Lyophilized (freeze-dried) powder

Vial strength

10mg

Total content

10 mg

Price per mg

$8.50

Sold by

Core Peptides

Ships from

United States

Lab report

Not yet published

Storage and preparation

Keep unopened freeze-dried vials cold, sealed and out of the light; moisture is what degrades a lyophilized cake fastest. After reconstitution, refrigerate the solution and work within the stability window your protocol sets.

Concentration arithmetic: one 10 mg vial dissolved in 2 mL gives 5 mg/mL, or 10 mg/mL in 1 mL. The Research Lab calculator in your dashboard handles any other volume.

Buyer questions

Supplied for laboratory research only. Not for human or veterinary use, and not a substitute for any prescription medicine. Nothing on this page is medical advice.